Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes

Gabriela B. Iwanski, MD, Nils H. Thoennissen, MD, Joy Nakitandwe, BSc, MSc, PhD, Patricia Lin, Norihiko Kawamata, Rahul Nahar, Parham Ramezani-Rad, Shann-Ching Chen, Sheila Shurtleff, PhD, Daniel Nowak, MD, Christian Ruckert, Martin Dugas, MD, Carsten Bokemeyer, MD, Grazia Fazio, Andrea Biondi, Professor, MD, Giovanni Cazzaniga, PhD, James R. Downing, MD, Markus Müschen, H. Phillip Koeffler, MD

Blood (2010) 116 (21): 3231.

https://doi.org/10.1182/blood.V116.21.3231.3231

Published: 2010

Journal Articles

The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug-Resistance in Chronic Myeloid Leukemia.

Lars Klemm, Cihangir Duy, Ilaria Iacobucci, PhD, Gregor von Levetzow, Niklas Feldhahn, Yong-mi Kim, Wolf-Karsten Hofmann, Hassan Jumaa, John Groffen, Nora Heisterkamp, Giovanni Martinelli, MD, Michael R Lieber, Rafael Casellas, Markus Müschen

Blood (2009) 114 (22): 3274.

https://doi.org/10.1182/blood.V114.22.3274.3274

Published: 2009

Journal Articles

BCL6 Is Critical for the Development of a Diverse Primary B Cell Repertoire.

Cihangir Duy, J. Jessica Yu, Srividya Swaminathan, Rahul R. Nahar, Soo-mi Kweon, Jose M. Polo, PhD, Ester Valls, Lars Klemm, Leandro Cerchietti, Gregor von Levetzow, Sebastian Herzog, Hassan Jumaa, Ignacio Moreno de Alborán, Ari Melnick, B. Hilda Ye, PhD, Markus Müschen

Blood (2009) 114 (22): 91.

https://doi.org/10.1182/blood.V114.22.91.91

Published: 2009

Journal Articles

Inactivation of Pre-B Cell Receptor-Mediated Tumor Suppression by Aberrant Splicing in Ph + Acute Lymphoblastic Leukemia.

Cihangir Duy, Mieke Sprangers, Lars Klemm, Rahul R. Nahar, Daniel Nowak, MD, Giovanni Martinelli, MD, Wolf-Karsten Hofmann, Phillip H Koeffler, MD, Hassan Jumaa, Markus Müschen

Blood (2009) 114 (22): 579.

https://doi.org/10.1182/blood.V114.22.579.579

Published: 2009

Journal Articles

Inducible Ablation of HSPA5 Suppresses BCR-ABL1 -Driven Leukemia through Massive Accumulation of Reactive Oxygen Species.

Mi Sook Chang, Shiuan Wey, Amy Lee, Markus Müschen

Blood (2009) 114 (22): 1976.

https://doi.org/10.1182/blood.V114.22.1976.1976

Published: 2009

Journal Articles

The Pax5 Fusion Product Pax5-C20orf112 Causes Downregulation of Pre-B Cell Receptor Genes and Induces Differential Proliferation Patterns in B-Lymphoblastic Cell Lines.

Daniel Nowak, MD, Norihiko Kawamata, MD, PhD, Birte Niebuhr, PhD, Verena Nowak, Maximilian Mossner, Rahul R Nahar, Nils Heinrich Thoennissen, MD, Gabriela B. Iwanski, MD, Carol Stocking, PhD, Martin Dugas, MD, PhD, Wolf Karsten Hofmann, MD, PhD, Markus Müschen, MD, PhD, Phillip H Koeffler, MD, PhD

Blood (2009) 114 (22): 1284.

https://doi.org/10.1182/blood.V114.22.1284.1284

Published: 2009

Journal Articles

BCL6 Is Required for Leukemia-Initiation and Self-Renewal Signaling in Chronic Myeloid Leukemia.

Christian Hurtz, Cihangir Duy, Leandro Cerchietti, Eugene Park, Weimin Ci, PhD, Srividya Swaminathan, Soo-mi Kweon, Lars Klemm, Yong-mi Kim, Giovanni Martinelli, Wolf-Karsten Hofmann, B. Hilda Ye, PhD, Ari Melnick, Markus Müschen

Blood (2009) 114 (22): 2167.

https://doi.org/10.1182/blood.V114.22.2167.2167

Published: 2009

Journal Articles

BCL6-Dependent Negative Regulation of Cell Cycle Checkpoint Regulators Enables Drug-Resistance in Ph + Acute Lymphoblastic Leukemia.

Cihangir Duy, Leandro Cerchietti, J. Jessica Yu, Weimin Ci, PhD, Srividya Swaminathan, Rahul R. Nahar, Soo-mi Kweon, Lars Klemm, B. Hilda Ye, PhD, Ari Melnick, Markus Müschen

Blood (2009) 114 (22): 765.

https://doi.org/10.1182/blood.V114.22.765.765

Published: 2009

Journal Articles

Activation-Induced Cytidine Deaminase Accelerates Clonal Evolution of BCR-ABL1 -Driven B Cell Lineage Acute Lymphoblastic Leukemia.

Tanja Gruber, Mi Sook Chang, Richard Sposto, PhD, Markus Müschen

Blood (2009) 114 (22): 181.

https://doi.org/10.1182/blood.V114.22.181.181

Published: 2009

Journal Articles

Obesity Accelerates T-Cell Leukemia in a Spontaneous Mouse Model.

Jason P Yun, Lars Klemm, James W Behan, Markus Müschen, MD, PhD, Steven D Mittelman, MD, PhD

Blood (2008) 112 (11): 1909.

https://doi.org/10.1182/blood.V112.11.1909.1909

Published: 2008

Journal Articles

Activation-Induced Cytidine Deaminase Acts as a Mutator in BCR-ABL1 -Transformed Acute Lymphoblastic Leukemia Cells.

Niklas Feldhahn, PhD, Florian Klein, MD, Wolf-Karsten Hofmann, MD, Janet D. Rowley, MD, Hassan Jumaa, PhD, Markus Müschen, MD

Blood (2006) 108 (11): 640.

https://doi.org/10.1182/blood.V108.11.640.640

Published: 2006

Journal Articles

Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion and IGL Gene Rearrangement.

Florian Klein, Niklas Feldhahn, Jana L. Mooster, Peter Wernet, MD, Markus Müschen, MD

Blood (2004) 104 (11): 315.

https://doi.org/10.1182/blood.V104.11.315.315

Published: 2004

Journal Articles

The BCR-ABL1 Kinase Interferes with Pre-B Cell Receptor Signal Transduction in B Cell Precursor Leukemia Cells.

Florian Klein, Niklas Feldhahn, Peter Wernet, MD, Markus Müschen, MD

Blood (2004) 104 (11): 1894.

https://doi.org/10.1182/blood.V104.11.1894.1894

Published: 2004

Journal Articles

Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions

Ralf Küppers, Andreas Bräuninger, Markus Müschen, Verena Distler, Martin-Leo Hansmann, Klaus Rajewsky

Blood (2001) 97 (3): 818–821.

https://doi.org/10.1182/blood.V97.3.818

Published: 2001

NARROW

Dominant-Negative Impact of PAX5/TEL on Downstream Targets of PAX5 and Essential Pre-B Cell Receptor Genes

The B Cell Mutator AID Promotes B Lymphoid Blast Crisis and Drug-Resistance in Chronic Myeloid Leukemia.

BCL6 Is Critical for the Development of a Diverse Primary B Cell Repertoire.

Inactivation of Pre-B Cell Receptor-Mediated Tumor Suppression by Aberrant Splicing in Ph + Acute Lymphoblastic Leukemia.

Inducible Ablation of HSPA5 Suppresses BCR-ABL1 -Driven Leukemia through Massive Accumulation of Reactive Oxygen Species.

The Pax5 Fusion Product Pax5-C20orf112 Causes Downregulation of Pre-B Cell Receptor Genes and Induces Differential Proliferation Patterns in B-Lymphoblastic Cell Lines.

BCL6 Is Required for Leukemia-Initiation and Self-Renewal Signaling in Chronic Myeloid Leukemia.

BCL6-Dependent Negative Regulation of Cell Cycle Checkpoint Regulators Enables Drug-Resistance in Ph + Acute Lymphoblastic Leukemia.

Activation-Induced Cytidine Deaminase Accelerates Clonal Evolution of BCR-ABL1 -Driven B Cell Lineage Acute Lymphoblastic Leukemia.

Obesity Accelerates T-Cell Leukemia in a Spontaneous Mouse Model.

Activation-Induced Cytidine Deaminase Acts as a Mutator in BCR-ABL1 -Transformed Acute Lymphoblastic Leukemia Cells.

Tracing the Pre-B to Immature B Cell Transition in Human Leukemia Cells Reveals a Coordinated Sequence of Primary and Secondary IGK Gene Rearrangement, IGK Deletion and IGL Gene Rearrangement.

The BCR-ABL1 Kinase Interferes with Pre-B Cell Receptor Signal Transduction in B Cell Precursor Leukemia Cells.

Evidence that Hodgkin and Reed-Sternberg cells in Hodgkin disease do not represent cell fusions

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only